Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Surveys and Questionnaires × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 25 Prostatic Neoplasms 22 Lung Neoplasms 11 Head and Neck Neoplasms 11 Pancreatic Neoplasms 8 Ovarian Neoplasms 7 Colorectal Neoplasms 7 Oropharyngeal Neoplasms 6 Hematologic Neoplasms 6 Gastrointestinal Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Depression 5 Brain Neoplasms 5 Sarcoma 4 Motor Activity 4 Lymphoma 4 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Pain 3 Osteosarcoma 3 Melanoma 3 Genetic Predisposition to Disease 3 Fatigue 3 Communication 3 Chronic Pain 3

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡